Treu Jesse I

Director at ALDX; Director at VCYT; 10% owner at Evoke Pharma Inc, and 10 more

Sold, on record
$74.1M
Dollars the filings state
Form 4 sales
45
Latest Mar 26, 2019
Form 144 notices
0
Proposed sales
Companies
13
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale CADENCE PHARMACEUTICALS INCUnusual
    Apr 15 2013

    Sold 71,578 shares at $6.62 ($474k)

    Treu Jesse I, 10% owner

    Sold 1% of holdings ($48.9M position)7.3M shares left20.4x usual sizeFiling

  2. 2 Form 4 sale ALIMERA SCIENCES INCPlan not stated
    Jun 11 +57 days

    Sold 59 shares at $5.00 ($295)

    Treu Jesse I, 10% owner

    Sold 0.1% of holdings ($202k position)40,248 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Evoke Pharma IncPlan not stated
    Aug 18 +798 days

    Sold 11,836 shares at $7.02 ($83k)

    Treu Jesse I, 10% owner

    Sold 1.1% of holdings ($7.5M position)1.1M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Evoke Pharma IncPlan not stated
    Apr 27 +253 days

    Sold 5,095 shares at $5.07 ($26k)

    Treu Jesse I, 10% owner

    Sold 0.5% of holdings ($4.8M position)950,403 shares leftFiling

  5. 5 Form 4 sale VCYTPlan not stated
    May 16 +384 days

    Sold 2,226 shares at $8.08 ($18k)

    Treu Jesse I, Director

    Sold 9.8% of holdings ($184k position)20,504 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale VCYTUnusual
    Aug 1 +442 days

    Sold 500,000 shares at $10.83 ($5.4M)

    Treu Jesse I, Director

    Sold 96.7% of holdings ($5.6M position)16,804 shares leftFiling

  7. 7 Form 4 sale VCYTUnusual
    Mar 4 +215 days

    Sold 1.1M shares at $20.37 ($21.4M)

    Treu Jesse I, Director

    Sold 100% of holdings ($21.4M position)0 shares leftFiling

  8. 8 Form 4 sale ALDXUnusual
    Mar 26 +22 days

    Sold 96,743 shares at $10.01 ($968k)

    Treu Jesse I, Director

    Sold 91.7% of holdings ($1.1M position)8,763 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (45)

Form 144 notices and Form 4 sales by Treu Jesse I
Source
Mar 26, 2019ALDXDirectorForm 4 sale96,743$968k91.7%UnusualSEC
Mar 4, 2019VCYTDirectorForm 4 sale1.1M$21.4M100.0%UnusualSEC
Aug 1, 2018VCYTDirectorForm 4 sale500,000$5.4M96.7%UnusualSEC
May 16, 2017VCYTDirectorForm 4 sale2,226$18k9.8%Plan not statedSEC
Apr 27, 2016Evoke Pharma Inc10% ownerForm 4 sale5,095$26k0.5%Plan not statedSEC
Aug 18, 2015Evoke Pharma Inc10% ownerForm 4 sale11,836$83k1.1%Plan not statedSEC
Jun 11, 2013ALIMERA SCIENCES INC10% ownerForm 4 sale59$2950.1%Plan not statedSEC
Apr 15, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale71,578$474k1.0%UnusualSEC
Mar 18, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale583$3k0.7%Plan not statedSEC
Mar 18, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale54,455$285k0.7%UnusualSEC
Mar 14, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale422$2k0.5%Plan not statedSEC
Mar 14, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale216$1k0.5%Plan not statedSEC
Mar 8, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale591$3k0.7%Plan not statedSEC
Mar 4, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale12,780$64k0.5%Plan not statedSEC
Feb 20, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale6,160$31k0.1%Plan not statedSEC
Feb 19, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale222$1k0.5%Plan not statedSEC
Feb 19, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale13,043$65k0.5%Plan not statedSEC
Feb 14, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale26,870$134k0.3%Plan not statedSEC
Jan 25, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale153,547$834k1.9%Plan not statedSEC
Jan 25, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale850$5k1.9%Plan not statedSEC
Jan 23, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale684$3k1.5%Plan not statedSEC
Jan 23, 2013CADENCE PHARMACEUTICALS INC10% ownerForm 4 sale40,320$205k1.5%Plan not statedSEC
Mar 23, 2012REVA Medical, Inc.10% ownerForm 4 sale1.7M$8.7M95.2%UnusualSEC
Jun 2, 2011ALIMERA SCIENCES INC10% ownerForm 4 sale6,914$56k14.5%Plan not statedSEC
Dec 18, 2009Somaxon Pharmaceuticals, Inc.DirectorForm 4 sale896,766$937k100.0%UnusualSEC
Dec 14, 2009Somaxon Pharmaceuticals, Inc.DirectorForm 4 sale35,000$40k78.8%UnusualSEC
Dec 11, 2009Somaxon Pharmaceuticals, Inc.DirectorForm 4 sale465,500$535k97.9%UnusualSEC
Jan 30, 2009NOVACEA INC10% ownerForm 4 sale250,000$239k78.6%UnusualSEC
Jul 16, 2008Volcano CORP10% ownerForm 4 sale19,357$280k23.6%Plan not statedSEC
Apr 8, 2008Volcano CORP10% ownerForm 4 sale16,832$218k17.7%Plan not statedSEC
Feb 26, 2008SENORX INCDirectorForm 4 sale2,750$23k11.1%Plan not statedSEC
Nov 27, 2007Orexigen Therapeutics, Inc.10% ownerForm 4 sale21,000$300k20.0%Plan not statedSEC
Jun 6, 2007NOVACEA INC10% ownerForm 4 sale24,500$276k25.0%Plan not statedSEC
Jun 5, 2007Somaxon Pharmaceuticals, Inc.DirectorForm 4 sale3,500$49k23.2%Plan not statedSEC
Jun 1, 2007Volcano CORP10% ownerForm 4 sale29,186$601k100.0%UnusualSEC
May 18, 2007Volcano CORP10% ownerForm 4 sale25,247$486k21.6%Plan not statedSEC
May 17, 2007Somaxon Pharmaceuticals, Inc.DirectorForm 4 sale4,297$62k22.2%Plan not statedSEC
May 15, 2007Northstar Neuroscience, Inc.DirectorForm 4 sale379,000$5M100.0%UnusualSEC
May 4, 2007Northstar Neuroscience, Inc.DirectorForm 4 sale15,971$208k100.0%UnusualSEC
Mar 5, 2007Northstar Neuroscience, Inc.DirectorForm 4 sale9,085$99k36.3%UnusualSEC
Dec 21, 2006Somaxon Pharmaceuticals, Inc.Director, 10% ownerForm 4 sale6,459$87k25.0%Plan not statedSEC
Dec 12, 2006VNDA10% ownerForm 4 sale12,900$330k38.0%UnusualSEC
Dec 6, 2006Volcano CORP10% ownerForm 4 sale1.5M$25.3M93.1%UnusualSEC
Nov 6, 2006Northstar Neuroscience, Inc.DirectorForm 4 sale12,530$164k33.3%UnusualSEC
Sep 18, 2006Somaxon Pharmaceuticals, Inc.Director, 10% ownerForm 4 sale6,459$84k20.0%Plan not statedSEC